{
    "Trade/Device Name(s)": [
        "artus HSV-1/2 QS-RGQ MDx Kit"
    ],
    "Submitter Information": "QIAGEN",
    "510(k) Number": "K142738",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100336"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "September 23, 2014",
    "Summary Letter Received Date": "September 23, 2014",
    "Submission Date": "November 24, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus 1 DNA",
        "Herpes Simplex Virus 2 DNA"
    ],
    "Specimen Type(s)": [
        "Genital lesion swab",
        "Oral lesion swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "QIAsymphony RGQ MDx system",
        "QIAsymphony SP/AS instrument",
        "Rotor-Gene Q MDx",
        "Rotor-Gene AssayManager software"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR DNA amplification",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "PCR",
        "Qualitative nucleic acid detection",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for artus HSV-1/2 QS-RGQ MDx Kit, a real-time PCR assay to qualitatively detect and differentiate HSV-1 and HSV-2 DNA in genital or oral lesion samples",
    "Indications for Use Summary": "In vitro real-time PCR DNA assay for direct qualitative detection and differentiation of HSV-1 and HSV-2 DNA in genital or oral vesicular lesions from male and female patients suspected of HSV infection; aids in diagnosis of HSV infection in symptomatic patients",
    "fda_folder": "Microbiology"
}